The evidence for using tenofovir disoproxil fumarate plus lamivudine as a nucleoside analogue backbone for the treatment of HIV

This article evaluates the evidence supporting use of the tenofovir disoproxil fumarate (TDF) plus lamivudine (3 ​TC) combination as a dual nucleoside backbone within a triple drug antiretroviral regimen. Key trials that assess the relative efficacy, safety and resistance profile of 3 ​TC and emtric...

Descripción completa

Detalles Bibliográficos
Autores principales: Waters, Laura, Mehta, Viraj, Gogtay, Jaideep, Boffito, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868802/
https://www.ncbi.nlm.nih.gov/pubmed/33598310
http://dx.doi.org/10.1016/j.jve.2021.100028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868802/
https://www.ncbi.nlm.nih.gov/pubmed/33598310
http://dx.doi.org/10.1016/j.jve.2021.100028

Ejemplares similares